PHLDA3 is an important downstream mediator of p53 in squamous cell carcinogenesis.
暂无分享,去创建一个
A. Kaneda | R. Ohki | K. Okumura | Megumi Saito | Y. Wakabayashi | Masaki Fukuyo | Yu Chen | Akane Sada | Y. Tabata | Kiyono Aoki | Rieko Ohki | Atsushi Kaneda
[1] R. Ohki,et al. p53-PHLDA3-Akt Network: The Key Regulators of Neuroendocrine Tumorigenesis , 2020, International journal of molecular sciences.
[2] A. Levine. p53: 800 million years of evolution and 40 years of discovery , 2020, Nature Reviews Cancer.
[3] H. Aburatani,et al. Identification and characterization of the binding sequences and target genes of p53 lacking the 1st transactivation domain , 2019, Cancer science.
[4] M. Kojima,et al. Recommendation of long-term and systemic management according to the risk factors in rectal NETs patients , 2019, Scientific Reports.
[5] H. Aburatani,et al. PHLDA1, another PHLDA family protein that inhibits Akt , 2018, Cancer science.
[6] Y. Sakakibara,et al. Time-Series Analysis of Tumorigenesis in a Murine Skin Carcinogenesis Model , 2018, Scientific Reports.
[7] L. Attardi,et al. Deciphering p53 signaling in tumor suppression. , 2018, Current opinion in cell biology.
[8] C. Blanpain,et al. Deciphering the cells of origin of squamous cell carcinomas , 2018, Nature Reviews Cancer.
[9] S. Sumi,et al. Pleckstrin homology-like domain family A, member 3 (PHLDA3) deficiency improves islets engraftment through the suppression of hypoxic damage , 2017, PloS one.
[10] Yusuke Nakamura,et al. The Transcriptional Landscape of p53 Signalling Pathway , 2017, EBioMedicine.
[11] R. Yi,et al. Cell-Type-Specific Chromatin States Differentially Prime Squamous Cell Carcinoma Tumor-Initiating Cells for Epithelial to Mesenchymal Transition. , 2017, Cell stem cell.
[12] C. Prives,et al. Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53. , 2017, Cold Spring Harbor perspectives in medicine.
[13] Benjamin J. Raphael,et al. Integrated genomic characterization of oesophageal carcinoma , 2017, Nature.
[14] H. Aburatani,et al. Novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cells , 2016, Cancer science.
[15] A. Rustgi,et al. Squamous Cell Cancers: A Unified Perspective on Biology and Genetics. , 2016, Cancer cell.
[16] D. Lambrechts,et al. Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma , 2015, Nature Medicine.
[17] Steven J. M. Jones,et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.
[18] Curtis R. Pickering,et al. Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma , 2014, Clinical Cancer Research.
[19] Y. Sakakibara,et al. Meis1 Regulates Epidermal Stem Cells and Is Required for Skin Tumorigenesis , 2014, PloS one.
[20] B. Tycko,et al. PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors , 2014, Proceedings of the National Academy of Sciences.
[21] Deyou Zheng,et al. SOX9: a stem cell transcriptional regulator of secreted niche signaling factors , 2014, Genes & development.
[22] Steven J. M. Jones,et al. Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.
[23] C. Blanpain,et al. Identifying the cellular origin of squamous skin tumors , 2011, Proceedings of the National Academy of Sciences.
[24] W. Lowry,et al. Defining the origins of Ras/p53-mediated squamous cell carcinoma , 2011, Proceedings of the National Academy of Sciences.
[25] David Lane,et al. p53 Research: the past thirty years and the next thirty years. , 2010, Cold Spring Harbor perspectives in biology.
[26] K. Kiguchi,et al. Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications , 2009, Nature Protocols.
[27] Tsutomu Ohta,et al. PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt , 2009, Cell.
[28] J. Paramio,et al. Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma. , 2009, Cancer research.
[29] F. Tashiro,et al. p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis , 2008, Oncogene.
[30] J. Paramio,et al. Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis. , 2007, Cancer research.
[31] Y. Taya,et al. Dissecting functional roles of p53 N‐terminal transactivation domains by microarray expression analysis , 2007, Cancer science.
[32] Hiroshi Masuya,et al. Enamelin (Enam) is essential for amelogenesis: ENU-induced mouse mutants as models for different clinical subtypes of human amelogenesis imperfecta (AI). , 2005, Human molecular genetics.
[33] Andreas Luch,et al. Nature and nurture – lessons from chemical carcinogenesis , 2005, Nature Reviews Cancer.
[34] B. Tycko,et al. Placental overgrowth in mice lacking the imprinted gene Ipl , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[35] T. Taniguchi,et al. Reprimo, a New Candidate Mediator of the p53-mediated Cell Cycle Arrest at the G2 Phase* , 2000, The Journal of Biological Chemistry.
[36] T. Taniguchi,et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. , 2000, Science.
[37] L. Donehower,et al. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors , 1993, Cell.
[38] A. Klein-Szanto,et al. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. , 1991, Cancer research.